US Patent Issued to Cornell University on April 8 for "Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies" (New York Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,759, issued on April 8, was assigned to Cornell University (Ithaca, N.Y.).

"Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies" was invented by John W. Babich (New York), James M. Kelly (New York), Alejandro Amor-Coarasa (New York) and Shashikanth Ponnala (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology provides compounds, as well as compositions including such compounds, useful for imaging and/or treatment of a glioma, a breast cancer, an adrenal cortical cancer, a cervical carcinoma, a vulvar carcinoma, an endometrial carcinoma, a primary ovarian carcinoma, a metastatic ...